Skip to main content

Table 2 Results of the captopril challenge test (CCT) in normal controls and patients

From: The captopril challenge test for diagnosing primary Aldosteronism in a Chinese population

Ā 

Pre-CCT

Post-CCT

PAC suppression percentage (%)

PRA (ng/ml.h)

PAC (ng/dl)

ARR

PRA (ng/ml.h)

PAC (ng/dl)

ARR

NC (nā€‰=ā€‰40)

1.4 (0.91~4.2)

13.2Ā Ā±Ā 4.7

6.9 (3.9~14.4)

3.0 (1.6~5.3) *

12.1Ā Ā±Ā 4.4ā€ 

3.9 (1.8~7.3) ā€ 

10.2 (āˆ’ā€‰2.6~20.8)

PH (nā€‰=ā€‰163)

2.3 (1.2~3.6)

13.6Ā Ā±Ā 3.9

6.1 (3.5~10.2)

3.3 (1.8~5.7) ā€ 

12.2Ā Ā±Ā 4.1ā€ 

3.4 (2.2~7.0) ā€ 

10.6 (āˆ’ā€‰1.4~21.5)

IHA (nā€‰=ā€‰28)

0.23 (0.05~0.36)AB

15.5Ā Ā±Ā 6.4ab

60.0 (34.8~169.2)AB

0.31 (0.20~0.58)ABā€ 

14.9Ā Ā±Ā 5.6aB

41.1 (27.9~61.2)AB

3.4 (āˆ’15.1~17.1)

APA (nā€‰=ā€‰82)

0.21 (0.048~0.35)AB

18.2Ā Ā±Ā 4.9ABC

80.0 (47.7~263.9)AB

0.30 (0.080~0.53)ABā€ 

17.4Ā Ā±Ā 5.0ABcā€ 

54.7 (35.2~196.9)AB

3.8 (āˆ’5.3~11.7)b

  1. Data are expressed as the meanā€‰Ā±ā€‰SD or median (25thā€“75th percentiles). APā€‰<ā€‰0.01, aPā€‰<ā€‰0.05 vs. NC; BPā€‰<ā€‰0.01, bPā€‰<ā€‰0.05 vs. PH; CPā€‰<ā€‰0.01, cPā€‰<ā€‰0.05 vs. IHA; *Pā€‰<ā€‰0.05, ā€ Pā€‰<ā€‰0.01 vs pre-CCT in each group